Adeno-Associated Virus

Adeno-associated viral (AAV) vectors play a central role in the delivery of gene therapies and as a vehicle for gene editing approaches. The Center for Breakthrough Medicines offers a full range of AAV production scales and platforms to serve the research, preclinical, clinical and commercial manufacturing clients including:

  • Transient transfection in both adherent and suspension cells
  • Baculovirus and other viral co-infection methods
  • Producer cell lines
  • Single-use technologies for streamlined clinical development processes
  • Testing and product characterization using next-generation analytical methods